Erratum: (Arteriosclerosis, Thrombosis, and Vascular Biology (2013) 33 (266-274) DOI: 10.1161/ATVBAHA.112.300384);Increased interstitial protein because of impaired lymph drainage does not induce fibrosis and inflammation in lymphedema

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 2, 2013, Pages 266-274

  Markhus, C E ^a   Karlsen, T V ^a   Wagner, M ^a   Svendsen, O S ^a,b   Tenstad, O ^a   Alitalo, K ^c   Wiig, H ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

cytokines; fluid balance; inflammation; lymphedema; mouse model

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; INTERSTITIAL PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CONTROLLED STUDY; FIBROSIS; INFLAMMATION; INTERSTITIAL FLUID; INTERSTITIUM; LYMPH FLOW; LYMPHATIC DRAINAGE; LYMPHEDEMA; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; TISSUE PRESSURE;

EID: 84872902113     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATV.0b013e3182960d1f     Document Type: Erratum

References (32)

1. Rockson SG. Lymphedema. Am J Med. 2001;110:288-295.
2. Wiig H, Swartz MA. Interstitial fuid and lymph formation and transport: physiological regulation and roles in infammation and cancer. Physiol Rev. 2012;92:1005-1060.
3. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE, Alitalo K. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA. 2001;98:12677-12682.
4. Karlsen T V, Karkkainen MJ, Alitalo K, Wiig H. Transcapillary fuid balance consequences of missing initial lymphatics studied in a mouse model of primary lymphoedema. J Physiol (Lond). 2006;574:583-596.
5. Mäkinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H, Nishikawa S, Ylä-Herttuala S, Alitalo K. Inhibition of lymphangiogenesis with resulting lymphedema in trans-genic mice expressing soluble VEGF receptor-3. Nat Med. 2001;7:199-205.
6. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438:946-953.
7. Wiig H, Reed RK, Aukland K. Micropuncture measurement of interstitial fuid pressure in rat subcutis and skeletal muscle: comparison to wick-in-needle technique. Microvasc Res. 1981;21:308-319.
8. Markhus CE, Wiig H. Isolation of interstitial fuid from skeletal muscle and subcutis in mice using a wick method. Am J Physiol Heart Circ Physiol. 2004;287:H2085-H2090.
9. Wiig H, Aukland K, Tenstad O. Isolation of interstitial fuid from rat mammary tumors by a centrifugation method. Am J Physiol Heart Circ Physiol. 2003;284:H416-H424.
10. Wiig H, Halleland EG, Fjaertoft M, Aukland K. Measurement of colloid osmotic pressure in submicrolitre samples. Acta Physiol Scand. 1988;132:445-452.
11. Rutkowski JM, Markhus CE, Gyenge CC, Alitalo K, Wiig H, Swartz MA. Dermal collagen and lipid deposition correlate with tissue swelling and hydraulic conductivity in murine primary lymphedema. Am J Pathol. 2010;176:1122-1129.
12. Karlsen TV, McCormack E, Mujic M, Tenstad O, Wiig H. Minimally invasive quantifcation of lymph fow in mice and rats by imaging depot clearance of near-infrared albumin. Am J Physiol Heart Circ Physiol. 2012;302:H391-H401.
13. Wiig H, Rubin K, Reed RK. New and active role of the interstitium in control of interstitial fuid pressure: potential therapeutic consequences. Acta Anaesthesiol Scand. 2003;47:111-121.
14. Aukland K, Reed RK. Interstitial-lymphatic mechanisms in the control of extracellular fuid volume. Physiol Rev. 1993;73:1-78.
15. Olszewski WL. Pathophysiological aspects of lymphedema of human limbs: I. Lymph protein composition. Lymphat Res Biol. 2003;1:235-243.
16. Kunstfeld R, Hirakawa S, Hong YK, Schacht V, Lange-Asschenfeldt B, Velasco P, Lin C, Fiebiger E, Wei X, Wu Y, Hicklin D, Bohlen P, Detmar M. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin infammation associated with persistent lymphatic hyperplasia. Blood. 2004;104:1048-1057.
17. Thomas SN, Rutkowski JM, Pasquier M, Kuan EL, Alitalo K, Randolph GJ, Swartz MA. Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage. J Immunol. 2012;189:2181-2190.
18. Saini A, Al-Shanti N, Nasser AS, Stewart CE. Waste management-cytokines, growth factors and cachexia. Cytokine Growth Factor Rev. 2006;17:475-486.
19. Guyton AC, Scheel K, Murphree D. Interstitial fuid pressure. 3. Its effect on resistance to tissue fuid mobility. Circ Res. 1966;19:412-419.
20. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cyto-kines. Immunol Rev. 2008;223:20-38.
21. Menten P, Wuyts A, Van Damme J. Macrophage infammatory protein-1. Cytokine Growth Factor Rev. 2002;13:455-481.
22. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoat-tractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29:313-326.
23. Naugler WE, Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, infammation and cancer. Trends Mol Med. 2008;14:109-119.
24. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol. 2004;4:665-674.
25. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3:133-146.
26. Avraham T, Daluvoy S, Zampell J, Yan A, Haviv YS, Rockson SG, Mehrara BJ. Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair. Am J Pathol. 2010;177:3202-3214.
27. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009;361:888-898.
28. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L, Shevach EM, O'shea JJ. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 2007;26:371-381.
29. Förster R, Braun A, Worbs T. Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol. 2012;33:271-280.
30. Alvarez D, Vollmann EH, von Andrian UH. Mechanisms and consequences of dendritic cell migration. Immunity. 2008;29:325-342.
31. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell traffcking to lymph nodes through lymphatic vessels. Nat Rev Immunol. 2005;5:617-628.
32. Sugaya M, Kuwano Y, Suga H, Miyagaki T, Ohmatsu H, Kadono T, Okochi H, Blauvelt A, Tamaki K, Sato S. Lymphatic dysfunction impairs antigen-specifc immunization, but augments tissue swelling following contact with allergens. J Invest Dermatol. 2012;132(3 Pt 1):667-676.